Precision radiation may extend time without cancer growth in Bone-Only metastases
NCT ID NCT03143322
First seen Jan 11, 2026 · Last updated May 11, 2026 · Updated 19 times
Summary
This study tests whether adding a high-dose, precise type of radiation called SBRT to standard treatments (like hormone therapy or chemotherapy) can delay cancer progression in people with solid tumors that have spread to 1 to 5 spots in the bones. It includes adults up to age 75 with breast, lung, or prostate cancer. The goal is to see if this approach improves how long patients live without their cancer getting worse.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Centre Amethyst CROM
Creil, France
-
Centre Catalan D'Oncologie
Perpignan, France
-
Centre Henri Becquerel
Rouen, France
-
Centre Léon Bérard
Lyon, France
-
Centre Léonard de Vinci
Dechy, France
-
Centre Marie Curie
Arras, France
-
Centre Oscar Lambret
Lille, France
-
Centre Pierre Curie
Beuvry, France
-
Centre d'oncologie et radiothérapie Saint-Jean
Saint-Doulchard, France
-
Centre de Cancérologie du Grand Montpellier
Montpellier, France
-
Chu Grenoble
Grenoble, France
-
Clinique Ambroise Pare
Beuvry, France
-
Clinique Tivoli Ducos
Bordeaux, France
-
Clinique des dentellières
Valenciennes, France
-
GCS RISSA - Institut de cancérologie Paris Nord
Sarcelles, France
-
Hôpital Henri Mondor
Créteil, France
-
Hôpital Métropole Savoie
Chambéry, France
-
Hôpital Privé Le Bois
Lille, France
-
Hôpital Privé Les Bonnettes
Arras, France
-
ICO - Site Paul Papin
Angers, France
-
Institut Bergonié
Bordeaux, France
-
Institut Jean Godinot
Reims, France
-
Institut Paoli Calmettes
Marseille, France
-
Institut Sainte Catherine
Avignon, France
-
Institut de Cancérologie de Bourgogne
Dijon, France
-
Institut de Cancérologie de Lorraine
Nancy, France
-
Institut de Cancérologie de l'Ouest
Nantes, France
-
Pôle Leonard de Vinci
Chambray-lès-Tours, France
Conditions
Explore the condition pages connected to this study.